American Portfolios Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.31M Sell
27,922
-1,102
-4% -$106K 0.1% 212
2022
Q2
$2.76M Sell
29,024
-1,644
-5% -$170K 0.11% 190
2022
Q1
$3.61M Sell
30,668
-8,275
-21% -$928K 0.12% 171
2021
Q4
$5.05M Buy
38,943
+5,431
+16% +$633K 0.17% 115
2021
Q3
$3.79M Buy
33,512
+2,092
+7% +$239K 0.14% 140
2021
Q2
$3.25M Buy
31,420
+174
+0.6% +$16.4K 0.13% 162
2021
Q1
$2.61M Buy
31,246
+1,616
+5% +$137K 0.11% 175
2020
Q4
$2.7M Buy
29,630
+1,198
+4% +$99.4K 0.14% 143
2020
Q3
$2.27M Buy
28,432
+2,358
+9% +$184K 0.13% 155
2020
Q2
$1.8M Sell
26,074
-2,030
-7% -$144K 0.12% 174
2020
Q1
$1.77M Sell
28,104
-9,144
-25% -$659K 0.15% 144
2019
Q4
$2.9M Buy
37,248
+12,087
+48% +$944K 0.21% 114
2019
Q3
$1.84M Sell
25,161
-3,159
-11% -$222K 0.15% 141
2019
Q2
$1.74M Sell
28,320
-3,009
-10% -$182K 0.15% 152
2019
Q1
$2M Buy
31,329
+681
+2% +$38.9K 0.19% 114
2018
Q4
$1.56M Buy
30,648
+28,500
+1,327% +$1.44M 0.19% 115
2018
Q3
$125K Buy
2,148
+75
+4% +$3.67K 0.01% 747
2018
Q2
$101K Sell
2,073
-321
-13% -$15K 0.01% 801
2018
Q1
$111K Buy
2,394
+111
+5% +$4.82K 0.02% 710
2017
Q4
$85.8K Buy
+2,283
New +$83.8K 0.01% 781

Other funds holding EW

American Portfolios Advisors's EW Position: Q3 2022 in Review

American Portfolios Advisors reduced its Edwards Lifesciences (EW) stake by 3.8% in Q3 2022, selling an estimated $106K and leaving 27,922 shares worth $2.31M. The position accounts for 0.1% of the portfolio, ranked #212.

American Portfolios Advisors first reported a position in EW in Q4 2017 and has held it in 20 quarters since. The position peaked at $5.05M in Q4 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • American Portfolios Advisors held 27,922 shares of Edwards Lifesciences worth $2.31M as of Q3 2022.
  • American Portfolios Advisors sold 1,102 Edwards Lifesciences shares in Q3 2022, an estimated $106K.
  • Edwards Lifesciences made up 0.1% of American Portfolios Advisors's portfolio in Q3 2022, its #212 holding.
  • American Portfolios Advisors first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Edwards Lifesciences position peaked at $5.05M in Q4 2021.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.